Browse All

Current Filters

CLEAR FILTER x

TITLE

Cladribine for the Treatment of Relapsing Multiple Sclerosis: The Northern Ireland Experience

Author:Philson, Emma   Kee, Rachael   McKee, Jon   Campbell, Jamie   Gray, Orla   McDonnell, Gavin   Hughes, Stella   Kennedy, Fiona   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.008  

Author Institution:Belfast Health and Social Care Trust, Belfast, United Kingdom  Southern Health and Social Care Trust, United Kingdom  South Eastern Health and Social Care Trust, United Kingdom  

Long-term Treatment Effects of Frexalimab on NfL, CXCL13, and Brain Volume Loss in Relapsing Multiple Sclerosis

Author:Granziera, Cristina   Vermersch, Patrick   Djukic, Biljana   Geertsen, Svend S.   Shafer, Andrea T.   Truffinet, Philippe   Giovannoni, Gavin   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine  Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland  University of Lille, Inserm U1172, Lille Neuroscience and Cognition, CHU Lille, FHU Precise, Lille, France, Lille, France  Sanofi, Cambridge, MA, USA, Cambridge, MA  Sanofi, Gentilly, France, Gentilly, France  Queen Mary University of London, London, UK, London, United Kingdom  

Longitudinal Lymphocyte, CD3, and Neutrophil Counts as Predictive Biomarkers for Infection Risk Following Anti-CD20 Therapy in Patients With MS

Author:Dodson, Cory   Jamal, Yaseen   Han, May   

Session Name:P4: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 1  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Stanford Neurology, Palo Alto, CA  Stanford, CA  Stanford University, Stanford, CA  

Rituximab in Demyelinating Disorders of the Central Nervous System: Real-world Insights From a Tertiary Institute in Pakistan

Author:Nishat, Sadia   Sheerani, Mughis   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Sindh Institute of Urology and Transplantation, Karachi, Pakistan  Neurogym, Karachi, Pakistan  

Preclinical Evidence Supporting Pilavapadin as a Novel Oral Therapy for Spasticity

Author:Gopinathan, Suma   Yang, Qi Melissa   Meilin, Sigal   Tyle, Praveen   Kigel-Zur, Keren   Levi, Isaac   Shulman, Yoav   Main, Alan   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.010  

Author Institution:Lexicon, The Woodlands, TX  MD Biosciences, Israel